BUY Dilip Buildcon Limited — Arun Kumar Mantri
byArun Kumar MantriHorizon: NA (inferred Swing (≤2wk))21 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Dilip Buildcon bags ₹1,265 crore transmission project in Maharashtra; shares gain
NewsCnbc-Tv18·21 Sept · today
Dilip Buildcon Limited has been declared the L-1 bidder by REC Power Development and Consultancy Limited for the development and operation of an intra-state transmission system in Maharashtra. The pro
NSE · Bagging/Receiving of orders/contracts·21 Sept · today
Dilip Buildcon Limited has been declared the lowest bidder (L-1) by REC Power Development and Consultancy Limited for a transmission system development and operation project.
BSE · Company Update·21 Sept · today
Dilip Buildcon share price rallies 10% after winning ₹1,800 crore order. Do you own?
NewsLivemint·10 Sept · 2w ago
Dilip Buildcon shares rally 12% on bagging Rs 1,800 crore LPG pipeline project
NewsEt-Markets·10 Sept · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Dilip Buildcon
- BUY — Prabhudas Lilladher11 Aug 2026 · ~1 year · target ₹507 · Active
- BUY — Sumeet Bagadia, Choice Broking5 Aug 2026 · ~2 weeks · target ₹500 · SL hit
- BUY — Pankaj Randad3 Aug 2026 · ~2 weeks · target ₹470 · SL hit
- SELL — Geojit Financial Services6 Jun 2025 · ~1 year · target ₹419 · Target hit
- SELL — Geojit Financial Services27 Feb 2025 · ~1 year · target ₹385 · Target hit
More from Arun Kumar Mantri
- BUY ACME Solar Holdings13 Nov 2026 · ~2 weeks · target ₹438 · SL hit
- BUY Cipla13 Nov 2026 · Same day · target ₹1,450 · Expired
- BUY Laurus Labs13 Nov 2026 · Same day · target ₹2,468 · Expired
- BUY Mankind Pharma13 Nov 2026 · Same day · target ₹2,710 · Expired
- BUY Oberoi Realty13 Nov 2026 · Same day · target ₹1,863 · SL hit

